How Does It Work?:
Esberitox is a unique blend of wild indigo root, coneflower root, and white cedar leaf that has been widely used in Europe for decades. This powerful combination of herbs fortifies the defense mechanism of body, supports to strengthen the body's natural defense mechanisms.

Research has shown that the Esberitox combination provides a broader range of activity than any individual component alone. This additive effect is produced via the actions and interactions of the concentrated botanical extracts. Although the activity of the individual components overlap in some way, each herb is unique in how it enhances immune function.

The following table summarizes the key benefits of each ingredient:

 

Ingredient	Benefits
Echinacea purpurea and pallida	·  Increase interferon production†   ·  Stimulates B-cell and antibody production†   ·  Increases interleukin-1 production†   ·  Increases production of tumor necrosis factor†
Wild indigo (Baptisia tinctoria	·  Increases interferon production†   ·  Stimulates B-cell and antibody production†   ·  Increases interleukin-1 production†
Thuja occidentalis (white cedar leaf)	·  Enhances T-4 Enhanceer cells and increases interleukin-2 production†
Esberitox	·  Increases chemotaxis of white blood cells†   ·  Increases phagocytosis rate and killing capacity of neutrophils†   ·  Activates macrophages†   ·  Increases phagocytosis of macrophages†

 

Clinical Research Findings
The safe and efficacious use of Esberitox in both children and adults has been documented in over thirty clinical and scientific studies. Unlike Echinacea, which has generated both negative and positive results, studies on the Esberitox combination have yielded only positive findings.

Defense mechanism of body Support
Several studies have examined the ability of Esberitox to quickly and effectively enhance Defense mechanism of body function. The powerful combination promotes the body's resistive functions by stimulating the production and activity of critical immune cells.

One randomized, double-blind, placebo controlled, multi-center study involving 263 adults, found that improvement was noticeable after only two days of supplementation - three days earlier than the placebo group. Similar benefits have been noted in children, where safety and tolerability have been established for those as young as two years of age.

Esberitox is especially beneficial when extra defense mechanism of body support is desired.† Clinical research has demonstrated that supplementation increased the rate of phagocytosis by 7.4%, whereas the rate in the placebo group decreased 3.2%. Phagocytosis is a process through which immune cells rid the body of waste and foreign bodies. Esberitox has also been shown to double the level of killer cell activity and the lymphocyte count in individuals in need of immune support.* These findings provide strong evidence of Esberitox's ability to stimulate the defense mechanism of body.